{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:25:48Z","timestamp":1778736348088,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s11604-021-01212-7","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T17:00:58Z","timestamp":1635872458000},"page":"396-403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Hepatic arterial infusion chemotherapy following simultaneous metallic stent placement and iodine-125 seed strands for advanced cholangiocarcinoma causing malignant obstructive jaundice: a propensity score matching study"],"prefix":"10.1007","volume":"40","author":[{"given":"Jun-Zheng","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong-Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Bin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8013-5607","authenticated-orcid":false,"given":"Wei-Zhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,2]]},"reference":[{"key":"1212_CR1","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/oxfordjournals.jjco.a023265","volume":"26","author":"M Iwasaki","year":"1996","unstructured":"Iwasaki M, Furuse J, Yoshino M, et al. Percutaneous transhepatic biliary drainage for the treatment of obstructive jaundice caused by metastases from nonbiliary and nonpancreatic cancers. Jpn J Clin Oncol. 1996;26:465\u20138.","journal-title":"Jpn J Clin Oncol"},{"key":"1212_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/BF01658484","volume":"12","author":"H Bismuth","year":"1988","unstructured":"Bismuth H, Castaing D, Traynor O. Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg. 1988;12:39\u201347.","journal-title":"World J Surg"},{"key":"1212_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1056\/NEJMe1001183","volume":"362","author":"BM Wolpin","year":"2010","unstructured":"Wolpin BM, Mayer RJ. A step forward in the treatment of advanced biliary tract cancer. N Engl J Med. 2010;362:1335\u20137.","journal-title":"N Engl J Med"},{"key":"1212_CR4","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1200\/JCO.18.02178","volume":"37","author":"RT Shroff","year":"2019","unstructured":"Shroff RT, Kennedy EB, Bachini M, et al. Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline. J Clin Oncol. 2019;37:1015\u201327.","journal-title":"J Clin Oncol"},{"key":"1212_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"A Jemal","year":"2009","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1212_CR6","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1572-0241.2007.01645.x","volume":"103","author":"A Larghi","year":"2008","unstructured":"Larghi A, Tringali A, Lecca PG, Giordano M, Costamagna G. Management of hilar biliary strictures. Am J Gastroenterol. 2008;103:458\u201373.","journal-title":"Am J Gastroenterol"},{"key":"1212_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1055\/s-0031-1291633","volume":"44","author":"JM Dumonceau","year":"2012","unstructured":"Dumonceau JM, Tringali A, Blero D, et al. Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2012;44:277\u201398.","journal-title":"Endoscopy"},{"issue":"5","key":"1212_CR8","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.jhep.2011.12.018","volume":"56","author":"HD Zhu","year":"2012","unstructured":"Zhu HD, Guo JH, Zhu GY, et al. A novel biliary stent loaded with 125I seeds in patients with malignant biliary obstruction: preliminary results versus a conventional biliary stent. J Hepatol. 2012;56(5):1104\u201311.","journal-title":"J Hepatol"},{"issue":"2","key":"1212_CR9","first-page":"1","volume":"31","author":"D Jiao","year":"2017","unstructured":"Jiao D, Wu G, Ren J, et al. Study of self-expandable metallic stent placement intraluminal (125)I seed strands brachytherapy of malignant biliary obstruction. Surg Endosc. 2017;31(2):1\u201310.","journal-title":"Surg Endosc"},{"issue":"4","key":"1212_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jvir.2016.11.038","volume":"28","author":"A Hasimu","year":"2017","unstructured":"Hasimu A, Gu JP, Ji WZ, et al. Comparative study of percutaneous transhepatic biliary stent placement with or without iodine-125 seeds for treating patients with malignant biliary obstruction. J Vasc Interv Radiol. 2017;28(4):583\u201393.","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"1212_CR11","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.brachy.2018.04.001","volume":"17","author":"J Ma","year":"2018","unstructured":"Ma J, Luo J, Gu J, et al. Malignant obstructive jaundice treated with intraluminal placement of Iodine-125 seed strands and metal stents: an analysis of long-term outcomes and prognostic features. Brachytherapy. 2018;17(4):689\u201395.","journal-title":"Brachytherapy"},{"issue":"2","key":"1212_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.bpg.2015.01.002","volume":"29","author":"N Schweitzer","year":"2015","unstructured":"Schweitzer N, Vogel A. Systemic therapy of cholangiocarcinoma: From chemotherapy to targeted therapies. Best Pract Res Clin Gastroenterol. 2015;29(2):345\u201353.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"14","key":"1212_CR13","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273\u201381.","journal-title":"N Engl J Med"},{"issue":"4","key":"1212_CR14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/sj.bjc.6605779","volume":"103","author":"T Okusaka","year":"2010","unstructured":"Okusaka T, Nakachi K, Fukutomi A, et al. Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer. 2010;103(4):469\u201374.","journal-title":"Br J Cancer"},{"issue":"5","key":"1212_CR15","first-page":"420","volume":"35","author":"CE Wu","year":"2012","unstructured":"Wu CE, Hsu HC, Shen WC, et al. Chemotherapy with gemcitabine plus cisplatin in patients with advanced biliary tract carcinoma at Chang Gung Memorial Hospital: a retrospective analysis. Chang Gung Med J. 2012;35(5):420\u20137.","journal-title":"Chang Gung Med J"},{"issue":"12","key":"1212_CR16","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.3390\/jcm10122552","volume":"10","author":"M Massani","year":"2021","unstructured":"Massani M, Bonariol L, Stecca T. Hepatic arterial infusion chemotherapy for unresectable intrahepatic cholangiocarcinoma, a comprehensive review. J Clin Med. 2021;10(12):2552.","journal-title":"J Clin Med"},{"issue":"2","key":"1212_CR17","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1148\/radiol.2016160572","volume":"283","author":"X Wang","year":"2017","unstructured":"Wang X, Hu J, Cao G, et al. Phase II study of hepatic arterial infusion chemotherapy with oxaliplatin and 5-fluorouracil for advanced perihilar cholangiocarcinoma. Radiology. 2017;283(2):580\u20139.","journal-title":"Radiology"},{"issue":"8","key":"1212_CR18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nrclinonc.2015.78","volume":"12","author":"A Habib","year":"2015","unstructured":"Habib A, Desai K, Hickey R, et al. Transarterial approaches to primary and secondary hepatic malignancies. Nat Rev Clin Oncol. 2015;12(8):481\u20139.","journal-title":"Nat Rev Clin Oncol"},{"key":"1212_CR19","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/cncr.20964","volume":"103","author":"M Cantore","year":"2005","unstructured":"Cantore M, Mambrini A, Fiorentini G, Rabbi C, Zamagni D, Caudana R, Pennucci C, Sanguinetti F, Lombardi M, Nicoli N. Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors. Cancer. 2005;103:1402\u20137.","journal-title":"Cancer"},{"key":"1212_CR20","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1093\/annonc\/mdp029","volume":"20","author":"WR Jarnagin","year":"2009","unstructured":"Jarnagin WR, Schwartz LH, Gultekin DH, G\u00f6nen M, Haviland D, Shia J, D\u2019Angelica M, Fong Y, DeMatteo R, Tse A, et al. Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. Ann Oncol. 2009;20:1589\u201395.","journal-title":"Ann Oncol"},{"key":"1212_CR21","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1159\/000362223","volume":"59","author":"F Ghiringhelli","year":"2014","unstructured":"Ghiringhelli F, Lorgis V, Vincent J, Ladoire S, Guiu B. Hepatic arterial infusion of gemcitabine plus oxaliplatin as secondline treatment for locally advanced intrahepatic cholangiocarcinoma: preliminary experience. Chemotherapy. 2014;59:354\u201360.","journal-title":"Chemotherapy"},{"key":"1212_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5582\/bst.2017.01320","volume":"12","author":"T Higaki","year":"2018","unstructured":"Higaki T, Aramaki O, Moriguchi M, Nakayama H, Midorikawa Y, Takayama T. Arterial infusion of cisplatin plus S-1 against unresectable intrahepatic cholangiocarcinoma. Biosci Trends. 2018;12:73\u20138.","journal-title":"Biosci Trends"},{"issue":"2","key":"1212_CR23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s00270-018-2117-7","volume":"42","author":"WZ Zhou","year":"2019","unstructured":"Zhou WZ, Fu YM, Yang ZQ, et al. Study of percutaneous stent placement with iodine-125 seed strand for malignant biliary obstruction. Cardiovasc Intervent Radiol. 2019;42(2):268\u201375.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"15","key":"1212_CR24","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1001\/jama.2015.13480","volume":"314","author":"JS Haukoos","year":"2015","unstructured":"Haukoos JS, Lewis RJ. The propensity score. J Am Med Assoc. 2015;314(15):1637\u20138.","journal-title":"J Am Med Assoc"},{"key":"1212_CR25","doi-asserted-by":"publisher","DOI":"10.1080\/00273171.2011.568786","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011. https:\/\/doi.org\/10.1080\/00273171.2011.568786.","journal-title":"Multivariate Behav Res"},{"key":"1212_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2017.10.029","author":"AA Sofi","year":"2017","unstructured":"Sofi AA, Khan MA, Das A, et al. Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc. 2017. https:\/\/doi.org\/10.1016\/j.gie.2017.10.029.","journal-title":"Gastrointest Endosc"},{"key":"1212_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.diii.2017.10.002","author":"B Acu","year":"2018","unstructured":"Acu B, Ozturk EK. Feasibility and safety of percutaneous transhepatic endobiliary radiofrequency ablation as an adjunct to biliary stenting in malignant biliary obstruction. Diagn Interv Imaging. 2018. https:\/\/doi.org\/10.1016\/j.diii.2017.10.002.","journal-title":"Diagn Interv Imaging"},{"issue":"Suppl. 1","key":"1212_CR28","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.5009\/gnl.2010.4.S1.S82","volume":"4 Suppl 1","author":"T Andra\u0161ina","year":"2010","unstructured":"Andra\u0161ina T, V\u00e1lek V, P\u00e1nek J, et al. Multimodal oncological therapy comprising stents, brachytherapy, and regional chemotherapy for cholangiocarcinoma. Gut Liver. 2010;4 Suppl 1(Suppl. 1):S82-8.","journal-title":"Gut Liver"},{"issue":"2","key":"1212_CR29","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3748\/wjg.v12.i2.331","volume":"12","author":"Q Xiao-Jun","year":"2006","unstructured":"Xiao-Jun Q, Ren-You Z, et al. Treatment of malignant biliary obstruction by combined percutaneous transhepatic biliary drainage with local tumor treatment. World J Gastroenterol. 2006;12(2):331\u20135.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"1212_CR30","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1159\/000367746","volume":"4","author":"S Obi","year":"2015","unstructured":"Obi S, Sato S, Kawai T. Current status of hepatic arterial infusion chemotherapy. Liver Cancer. 2015;4(3):188\u201399.","journal-title":"Liver Cancer"},{"issue":"1","key":"1212_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/COC.0b013e3181d2709a","volume":"34","author":"Y Inaba","year":"2011","unstructured":"Inaba Y, Arai Y, Yamaura H, et al. Phase I\/II study of hepatic arterial infusion chemotherapy with gemcitabine in patients with unresectable intrahepatic cholangiocarcinoma (JIVROSG-0301). Am J Clin Oncol. 2011;34(1):58\u201362.","journal-title":"Am J Clin Oncol"},{"issue":"14","key":"1212_CR32","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273\u201381.","journal-title":"N Engl J Med"},{"issue":"9","key":"1212_CR33","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/annonc\/mdh351","volume":"15","author":"T Andr\u00e9","year":"2004","unstructured":"Andr\u00e9 T, Tournigand C, Rosmorduc O, et al. Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Ann Oncol. 2004;15(9):1339\u201343.","journal-title":"Ann Oncol"},{"issue":"3","key":"1212_CR34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s002800100333","volume":"48","author":"IG Finlay","year":"2001","unstructured":"Finlay IG, Stewart GJ, Shirley P, et al. Hepatic arterial and intravenous administration of 1,25-dihydroxyvitamin D3\u2013evidence of a clinically significant hepatic first-pass effect. Cancer Chemother Pharmacol. 2001;48(3):209\u201314.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1212_CR35","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2019.1694","author":"J Datta","year":"2019","unstructured":"Datta J, Narayan RR, Kemeny NE, et al. Role of hepatic artery infusion chemotherapy in treatment of initially unresectable colorectal liver metastases: a review. JAMA Surg. 2019. https:\/\/doi.org\/10.1001\/jamasurg.2019.1694.","journal-title":"JAMA Surg"},{"issue":"4","key":"1212_CR36","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000486483","volume":"94","author":"K Kodama","year":"2018","unstructured":"Kodama K, Kawaoka T, Aikata H, et al. Comparison of outcome of hepatic arterial infusion chemotherapy combined with radiotherapy and sorafenib for advanced hepatocellular carcinoma patients with major portal vein tumor thrombosis. Oncology. 2018;94(4):215\u201322.","journal-title":"Oncology"},{"issue":"3","key":"1212_CR37","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jvir.2018.09.004","volume":"30","author":"N Lyu","year":"2019","unstructured":"Lyu N, Kong Y, Pan T, et al. Hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin in hepatocellular cancer with extrahepatic spread. J Vasc Interv Radiol. 2019;30(3):349\u201357.","journal-title":"J Vasc Interv Radiol"},{"issue":"10","key":"1212_CR38","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1007\/s00330-016-4208-7","volume":"26","author":"Y Chen","year":"2016","unstructured":"Chen Y, Li H, Jiang X, et al. Regional thermochemotherapy versus hepatic arterial infusion chemotherapy for palliative treatment of advanced hilar cholangiocarcinoma: a retrospective controlled study. Eur Radiol. 2016;26(10):3500\u20139.","journal-title":"Eur Radiol"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-021-01212-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-021-01212-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-021-01212-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T23:04:38Z","timestamp":1649027078000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11604-021-01212-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,2]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1212"],"URL":"https:\/\/doi.org\/10.1007\/s11604-021-01212-7","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,2]]},"assertion":[{"value":"18 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}